Moderna said Thursday that it is pausing its plans to build an mRNA vaccine manufacturing facility in Kenya as demand for mRNA vaccines lags in Africa . The Massachusetts-based vaccine maker says the continent’s uptake of COVID-19 vaccines is no longer sufficient enough to support the project. Dow closes 400 points lower on surprising inflation data CC Share Subtitles Off English English Share this Video Facebook Twitter Email Reddit Link view video Dow closes 400 points lower on surprising